Over the last decades, the negative health consequences of obesity have triggered massive searches for the cause of – and potential solutions for – the excessive mismatch between calorie consumption and expenditure. The concepts of malfunctioning hypothalamic neurotransmission and impaired related neuromodulatory networks in other brain regions have attracted considerable attention as they may partially explain metabolic abnormalities. While numerous and important efforts are underway to scientifically dissect the neuronal signaling pathways involved in metabolic sensing and regulation, the roles of astroglial cells represent a relatively understudied area. This gap in knowledge is particularly evident in the neuroendocrine control of glucose and lipid metabolism. This review presents evidence that in regard to metabolism, astrocytes act not only as an energy supplier for neurons, but may also play key roles in metabolic sensing by expressing metabolic related receptors and regulators. Moreover, the astrocytosis observed during calorie-rich high-fat diet indicates that astrocytes could be involved in developing metabolic abnormalities. Finally, potential obstacles and pitfalls for studying the role of astrocytes in metabolic sensing and regulation are discussed.

1.
Banks WA: Blood-brain barrier as a regulatory interface. Forum Nutr 2010;63:102–110.
2.
Haydon PG, Carmignoto G: Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006;86:1009–1031.
3.
Filosa JA, Blanco VM: Neurovascular coupling in the mammalian brain. Exp Physiol 2007;92:641–646.
4.
Fields RD, Stevens-Graham B: New insights into neuron-glia communication. Science 2002;298:556–562.
5.
Horvath TL, Sarman B, Garcia-Caceres C, Enriori PJ, Sotonyi P, Shanabrough M, Borok E, Argente J, Chowen JA, Perez-Tilve D, Pfluger PT, Bronneke HS, Levin BE, Diano S, Cowley MA, Tschöp MH: Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc Natl Acad Sci USA 2010;107:14875–14880.
6.
Hawkins RA, Williamson DH, Krebs HA: Ketone-body utilization by adult and suckling rat brain in vivo. Biochem J 1971;122:13–18.
7.
Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF Jr: Brain metabolism during fasting. J Clin Invest 1967;46:1589–1595.
8.
Robinson AM, Williamson DH: Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 1980;60:143–187.
9.
Gjedde A, Crone C: Induction processes in blood-brain transfer of ketone bodies during starvation. Am J Physiol 1975;229:1165–1169.
10.
Zivin JA, Snarr JF: Glucose and D(–)-3-hydroxybutyrate uptake by isolated perfused rat brain. J Appl Physiol 1972;32:664–668.
11.
Lopes-Cardozo M, Larsson OM, Schousboe A: Acetoacetate and glucose as lipid precursors and energy substrates in primary cultures of astrocytes and neurons from mouse cerebral cortex. J Neurochem 1986;46:773–778.
12.
Miller JC, Gnaedinger JM, Rapoport SI: Utilization of plasma fatty acid in rat brain: distribution of [14C]palmitate between oxidative and synthetic pathways. J Neurochem 1987;49:1507–1514.
13.
Guzman M, Blazquez C: Is there an astrocyte-neuron ketone body shuttle? Trends Endocrinol Metab 2001;12:169–173.
14.
Staub F, Winkler A, Peters J, Goerke U, Kempski O, Baethmann A: Clearance and metabolism of arachidonic acid by C6 glioma cells and astrocytes. Neurochem Res 1995;20:1449–1456.
15.
Edmond J: Energy metabolism in developing brain cells. Can J Physiol Pharmacol 1992;70(suppl):S118–S129.
16.
Cullingford TE, Dolphin CT, Bhakoo KK, Peuchen S, Canevari L, Clark JB: Molecular cloning of rat mitochondrial 3-hydroxy-3-methylglutaryl-CoA lyase and detection of the corresponding mRNA and of those encoding the remaining enzymes comprising the ketogenic 3-hydroxy-3-methylglutaryl-CoA cycle in central nervous system of suckling rat. Biochem J 1998;329:373–381.
17.
Sunny NE, Satapati S, Fu X, He T, Mehdibeigi R, Spring-Robinson C, Duarte J, Potthoff MJ, Browning JD, Burgess SC: Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. Am J Physiol Endocrinol Metab 2010;298:E1226–E1235.
18.
Moore TJ, Lione AP, Sugden MC, Regen DM: Beta-hydroxybutyrate transport in rat brain: developmental and dietary modulations. Am J Physiol 1976;230:619–630.
19.
Melo TM, Nehlig A, Sonnewald U: Neuronal-glial interactions in rats fed a ketogenic diet. Neurochem Int 2006;48:498–507.
20.
Hasselbalch SG, Knudsen GM, Jakobsen J, Hageman LP, Holm S, Paulson OB: Blood-brain barrier permeability of glucose and ketone bodies during short-term starvation in humans. Am J Physiol 1995;268:E1161–E1166.
21.
Crane PD, Pardridge WM, Braun LD, Oldendorf WH: Two-day starvation does not alter the kinetics of blood-brain barrier transport and phosphorylation of glucose in rat brain. J Cereb Blood Flow Metab 1985;5:40–46.
22.
Redies C, Hoffer LJ, Beil C, Marliss EB, Evans AC, Lariviere F, Marrett S, Meyer E, Diksic M, Gjedde A: Generalized decrease in brain glucose metabolism during fasting in humans studied by PET. Am J Physiol 1989;256:E805–E810.
23.
Halestrap AP, Price NT: The proton-linked monocarboxylate transporter family: structure, function and regulation. Biochem J 1999;343:281–299.
24.
Broer S, Rahman B, Pellegri G, Pellerin L, Martin JL, Verleysdonk S, Hamprecht B, Magistretti PJ: Comparison of lactate transport in astroglial cells and monocarboxylate transporter 1 (MCT-1) expressing Xenopus laevis oocytes. Expression of two different monocarboxylate transporters in astroglial cells and neurons. J Biol Chem 1997;272:30096–30102.
25.
Lin T, Koustova E, Chen H, Rhee PM, Kirkpatrick J, Alam HB: Energy substrate-supplemented resuscitation affects brain monocarboxylate transporter levels and gliosis in a rat model of hemorrhagic shock. J Trauma 2005;59:1191–1202.
26.
Leino RL, Gerhart DZ, Duelli R, Enerson BE, Drewes LR: Diet-induced ketosis increases monocarboxylate transporter (MCT-1) levels in rat brain. Neurochem Int 2001;38:519–527.
27.
Schachtrup C, Ryu JK, Helmrick MJ, Vagena E, Galanakis DK, Degen JL, Margolis RU, Akassoglou K: Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-β after vascular damage. J Neurosci 2010;30:5843–5854.
28.
Ramirez Alvarado MM, Sanchez RC, Perez DA, Millan BE: Effect of a high saturated fatty acids load on serum concentrations of C-reactive protein, α1-antitrypsin, fibrinogen and α1-acid glycoprotein in obese women (in Spanish). Nutr Hosp 2010;25:72–79.
29.
Ciofi P: The arcuate nucleus as a circumventricular organ in the mouse. Neurosci Lett 2010.
30.
Ciofi P, Garret M, Lapirot O, Lafon P, Loyens A, Prevot V, Levine JE: Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology 2009;150:5509–5519.
31.
Mullier A, Bouret SG, Prevot V, Dehouck B: Differential distribution of tight junction proteins suggests a role for tanycytes in blood-hypothalamus barrier regulation in the adult mouse brain. J Comp Neurol 2010;518:943–962.
32.
Cottrell GT, Ferguson AV: Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept 2004;117:11–23.
33.
Schwartz MW, Seeley RJ, Campfield LA, Burn P, Baskin DG: Identification of targets of leptin action in rat hypothalamus. J Clin Invest 1996;98:1101–1106.
34.
Unger J, McNeill TH, Moxley RT III, White M, Moss A, Livingston JN: Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 1989;31:143–157.
35.
Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, Mucke L: Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6. Proc Natl Acad Sci USA 1993;90:10061–10065.
36.
Hidalgo J, Florit S, Giralt M, Ferrer B, Keller C, Pilegaard H: Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. Brain Behav Immun 2010;24:119–126.
37.
Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ: Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 1990;247:470–473.
38.
Parpura V, Zorec R: Gliotransmission: exocytotic release from astrocytes. Brain Res Rev 2010;63:83–92.
39.
Park JB, Skalska S, Stern JE: Characterization of a novel tonic γ-aminobutyric acid A receptor-mediated inhibition in magnocellular neurosecretory neurons and its modulation by glia. Endocrinology 2006;147:3746–3760.
40.
Park JB, Jo JY, Zheng H, Patel KP, Stern JE: Regulation of tonic GABA inhibitory function, presympathetic neuronal activity and sympathetic outflow from the paraventricular nucleus by astroglial GABA transporters. J Physiol 2009;587:4645–4660.
41.
Berger J, Moller DE: The mechanisms of action of PPARs. Annu Rev Med 2002;53:409–435.
42.
Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx J: Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor α-deficient mice. J Biol Chem 1997;272:27307–27312.
43.
Konig B, Koch A, Giggel K, Dordschbal B, Eder K, Stangl GI: Monocarboxylate transporter-1 is up-regulated by PPARα. Biochim Biophys Acta 2008;1780:899–904.
44.
Mahley RW, Innerarity TL, Rall SC Jr, Weisgraber KH: Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 1984;25:1277–1294.
45.
Weisgraber KH: Apolipoprotein E: structure-function relationships. Adv Protein Chem 1994;45:249–302.
46.
Haft DE, Roheim PS, White A, Eder HA: Plasma lipoprotein metabolism in perfused rat livers. I. Protein synthesis and entry into the plasma. J Clin Invest 1962;41:842–849.
47.
Boyles JK, Pitas RE, Wilson E, Mahley RW, Taylor JM: Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J Clin Invest 1985;76:1501–1513.
48.
Shen L, Tso P, Woods SC, Clegg DJ, Barber KL, Carey K, Liu M: Brain apolipoprotein E: an important regulator of food intake in rats. Diabetes 2008;57:2092–2098.
49.
Shen L, Tso P, Wang DQ, Woods SC, Davidson WS, Sakai R, Liu M: Up-regulation of apolipoprotein E by leptin in the hypothalamus of mice and rats. Physiol Behav 2009;98:223–228.
50.
Young JK: Anatomical relationship between specialized astrocytes and leptin-sensitive neurones. J Anat 2002;201:85–90.
51.
Leshan RL, Louis GW, Jo YH, Rhodes CJ, Munzberg H, Myers MG Jr: Direct innervation of GnRH neurons by metabolic- and sexual odorant-sensing leptin receptor neurons in the hypothalamic ventral premammillary nucleus. J Neurosci 2009;29:3138–3147.
52.
Hsuchou H, Pan W, Barnes MJ, Kastin AJ: Leptin receptor mRNA in rat brain astrocytes. Peptides 2009;30:2275–2280.
53.
Hsuchou H, He Y, Kastin AJ, Tu H, Markadakis EN, Rogers RC, Fossier PB, Pan W: Obesity induces functional astrocytic leptin receptors in hypothalamus. Brain 2009;132:889–902.
54.
Lee MY, Deller T, Kirsch M, Frotscher M, Hofmann HD: Differential regulation of ciliary neurotrophic factor (CNTF) and CNTF receptor α expression in astrocytes and neurons of the fascia dentata after entorhinal cortex lesion. J Neurosci 1997;17:1137–1146.
55.
Lanz TV, Ding Z, Ho PP, Luo J, Agrawal AN, Srinagesh H, Axtell R, Zhang H, Platten M, Wyss-Coray T, Steinman L: Angiotensin II sustains brain inflammation in mice via TGF-β. J Clin Invest 2010;120:2782–2794.
56.
Steinberg GR, Watt MJ, Fam BC, Proietto J, Andrikopoulos S, Allen AM, Febbraio MA, Kemp BE: Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 2006;147:3906–3914.
57.
Watt MJ, Dzamko N, Thomas WG, Rose-John S, Ernst M, Carling D, Kemp BE, Febbraio MA, Steinberg GR: CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat Med 2006;12:541–548.
58.
Levin BE, Dunn-Meynell AA, Routh VH: Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 1999;276:R1223–R1231.
59.
Ngarmukos C, Baur EL, Kumagai AK: Co-localization of GLUT1 and GLUT4 in the blood-brain barrier of the rat ventromedial hypothalamus. Brain Res 2001;900:1–8.
60.
Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W, Routh VH: The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 2004;53:1959–1965.
61.
Wang X, Takano T, Nedergaard M: Astrocytic calcium signaling: mechanism and implications for functional brain imaging. Methods Mol Biol 2009;489:93–109.
62.
Koizumi S: Synchronization of Ca2+ oscillations: involvement of ATP release in astrocytes. FEBS J 2010;277:286–292.
63.
Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, Bruce-Keller AJ: Cognitive impairment following high-fat diet consumption is associated with brain inflammation. J Neuroimmunol 2010;219:25–32.
64.
Zhang Y, Barres BA: Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol 2010;20:588–594.
65.
Middeldorp J, van den Berge SA, Aronica E, Speijer D, Hol EM: Specific human astrocyte subtype revealed by affinity purified GFAP antibody; unpurified serum cross-reacts with neurofilament-L in Alzheimer. PLoS ONE 2009;4:e7663.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.